BR0302590A - Agente para tratamento de tumores sólidos - Google Patents

Agente para tratamento de tumores sólidos

Info

Publication number
BR0302590A
BR0302590A BR0302590-0A BR0302590A BR0302590A BR 0302590 A BR0302590 A BR 0302590A BR 0302590 A BR0302590 A BR 0302590A BR 0302590 A BR0302590 A BR 0302590A
Authority
BR
Brazil
Prior art keywords
solid tumors
agent
treatment
arabinopyranoside
hederagenin
Prior art date
Application number
BR0302590-0A
Other languages
English (en)
Inventor
Song-Bae Kim
Byung-Zun Ahn
Yong Kim
Original Assignee
Song-Bae Kim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Song-Bae Kim filed Critical Song-Bae Kim
Publication of BR0302590A publication Critical patent/BR0302590A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

"AGENTE PARA TRATAMENTO DE TUMORES SóLIDOS". Esta invenção diz respeito a um uso de hederagenina 3-O-<244>-L-ramnopiranosil(1->2)-[<225>-D-glucopiranosil(1->4)-<2 44>-L-arabinopiranosídeo ou um extrato de Pulsatillae radix contendo a mesma como um agente terapêutico para tumores sólidos.
BR0302590-0A 2002-07-22 2003-07-17 Agente para tratamento de tumores sólidos BR0302590A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020020043016A KR100568607B1 (ko) 2002-07-22 2002-07-22 헤데라게닌3-Ｏ-α-Ｌ-람노피라노실(1→2)-[β-Ｄ-글루코피라노실(1→4)]-α-Ｌ-아라비노피라노사이드 또는 그를 함유하는백두옹 추출물의 고형암 치료제로서의 용도

Publications (1)

Publication Number Publication Date
BR0302590A true BR0302590A (pt) 2004-08-24

Family

ID=30439383

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0302590-0A BR0302590A (pt) 2002-07-22 2003-07-17 Agente para tratamento de tumores sólidos

Country Status (15)

Country Link
US (3) US20040082528A1 (pt)
EP (1) EP1388542B1 (pt)
JP (1) JP4642330B2 (pt)
KR (1) KR100568607B1 (pt)
CN (1) CN1308000C (pt)
AT (1) ATE373670T1 (pt)
AU (1) AU2003208120B2 (pt)
BR (1) BR0302590A (pt)
CA (1) CA2435524C (pt)
DE (1) DE60316389T2 (pt)
DK (1) DK1388542T3 (pt)
ES (1) ES2292883T3 (pt)
MX (1) MXPA03006473A (pt)
RU (1) RU2325178C2 (pt)
TW (1) TWI280881B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP702498A0 (en) * 1998-11-09 1998-12-03 Silverbrook Research Pty Ltd Image creation method and apparatus (ART77)
US20050163734A1 (en) * 2002-09-23 2005-07-28 Kim Jong S. Cosmetic composition having whitening effect comprising extract of pulsatilla radix as main ingredient
KR100667955B1 (ko) * 2004-05-07 2007-01-15 주식회사 에스비피 백두옹으로부터 분리된 트리터펜 사포닌 및 이를 포함하는항-고형암 조성물
KR100628334B1 (ko) * 2004-07-30 2006-09-27 김송배 백두옹의 항암효과를 증진시키는 방법 및 이 방법으로제조된 항암 조성물
JP4892833B2 (ja) * 2004-12-17 2012-03-07 大正製薬株式会社 脂肪吸収抑制剤
ES2494919T3 (es) 2005-02-03 2014-09-16 Sk Chemicals Co., Ltd. Extractos de Pulsatilla spp. eficaces en la función cerebral
KR100748248B1 (ko) * 2006-06-26 2007-08-10 주식회사 에스비피 백두옹으로부터 분리된 트리터펜 사포닌 및 이를 포함하는항-고형암 조성물
CN102178688B (zh) * 2011-04-07 2012-11-21 江西本草天工科技有限责任公司 一种常春藤皂苷类成分的制备方法及其抗肿瘤的用途
CN102199184B (zh) * 2011-04-07 2013-03-06 江西本草天工科技有限责任公司 一种常春藤皂苷类衍生物、其盐的制备方法及其抗肿瘤的用途
CN102633857A (zh) * 2012-04-24 2012-08-15 吉林大学 一种常春藤皂苷元的提取方法
JP2012246311A (ja) * 2012-09-05 2012-12-13 Sk Chemicals Co Ltd 脳機能改善効果を有するオキナグサ抽出物
CN104622880B (zh) * 2015-02-09 2017-05-17 南京医科大学第一附属医院 一种抗肿瘤药物组合物
CN104761610A (zh) * 2015-02-10 2015-07-08 江西本草天工科技有限责任公司 一类新型的α-常春藤皂苷衍生物及其制备方法和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670523A (pt) * 1964-10-09
KR940000234B1 (ko) * 1989-09-04 1994-01-12 김송배 신규 항암작용을 가지는 약학적 제제 및 제조방법
US5098870A (en) * 1990-07-12 1992-03-24 Lanxide Technology Company, Lp Process for preparing self-supporting bodies having controlled porosity and graded properties and products produced thereby
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
KR0128494B1 (ko) * 1994-07-26 1998-04-04 최무섭 색전이 없는 생약 추출물-함유 줄무늬 치약 조성물
RU2112530C1 (ru) * 1994-09-27 1998-06-10 Евгений Иванович Трифонов Способ лечения опухолей
KR100205045B1 (ko) * 1996-12-05 1999-06-15 김송배 신규한 트리테르펜 글리코사이드 화합물, 그의 제조방법 및 그를 함유하는 항암제 조성물
ATE340191T1 (de) * 1997-07-02 2006-10-15 Univ Washington Methoden zur isolation von proteinaseinhibitor proteinen von kartoffeln knollen
KR19990016761A (ko) * 1997-08-19 1999-03-15 김송배 신규한 트리테르펜 글리코사이드 화합물, 그의 제조방법 및 그를 함유하는 항암제 조성물
KR100312622B1 (ko) * 1998-11-03 2002-02-28 김송배 생약을주성분으로한안정화된항암제조성물및그제조방법
KR100315200B1 (ko) 1998-11-10 2002-03-21 김송배 데옥시포도필로톡신을유효성분으로함유하는고형암치료제조성물
KR100340941B1 (ko) * 1999-05-14 2002-06-20 김일웅 항 종양 효과가 있는 화합물 및 그것을 함유하는 항종양제
US7371418B2 (en) * 2001-07-06 2008-05-13 Sheabar Fayad Z Method for controlling the yield and purity of proteinase inhibitor II during extraction
US6686456B2 (en) * 2001-07-06 2004-02-03 Kemin Foods, L.C. Method for the elimination of Kunitz and Bowman-Birk trypsin inhibitors and carboxypeptidase inhibitor from potato proteins

Also Published As

Publication number Publication date
ES2292883T3 (es) 2008-03-16
RU2325178C2 (ru) 2008-05-27
US20050239718A1 (en) 2005-10-27
DE60316389T2 (de) 2008-06-26
AU2003208120B2 (en) 2008-09-11
US20040082528A1 (en) 2004-04-29
CA2435524A1 (en) 2004-01-22
CN1494910A (zh) 2004-05-12
TWI280881B (en) 2007-05-11
MXPA03006473A (es) 2004-02-04
KR100568607B1 (ko) 2006-04-07
AU2003208120A1 (en) 2004-02-05
CN1308000C (zh) 2007-04-04
DK1388542T3 (da) 2008-01-02
JP4642330B2 (ja) 2011-03-02
CA2435524C (en) 2009-11-03
US20100152124A1 (en) 2010-06-17
US7682638B2 (en) 2010-03-23
JP2004051641A (ja) 2004-02-19
EP1388542A1 (en) 2004-02-11
KR20040009172A (ko) 2004-01-31
DE60316389D1 (de) 2007-10-31
TW200410704A (en) 2004-07-01
EP1388542B1 (en) 2007-09-19
US8075923B2 (en) 2011-12-13
RU2003122817A (ru) 2005-01-27
ATE373670T1 (de) 2007-10-15

Similar Documents

Publication Publication Date Title
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
BR0302590A (pt) Agente para tratamento de tumores sólidos
ECSP077324A (es) Amidas bicíclicas como inhibidores de cinasa
UY27943A1 (es) Composiciones y mctodos para tratar el crncer usando inmunoconjugados de anticuerpo para cd44 citotnxicos y agentes quimioterapcuticos
GT200500158A (es) Derivados de amino-5,5-difenilimidazolona para la inhibicion de la b-secretasa
SV2006002134A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis ref. 5195-sv
NO20071585L (no) Ny anvendelse av peptidforbindelser for behandling av benkreftsmerte, kjemoterapi- og nucleosidfremkalt smerte
BRPI0611717A2 (pt) composto, composiÇço farmacÊutica e uso do composto
BR0213358A (pt) Uso de flibanserina
BRPI0413255A (pt) uso de uma combinação de um inibidor de quinase do receptor do fator de crescimento epidérmico e agentes citotóxicos para tratamento e inibição do cáncer
DK1663242T3 (da) 2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler
CL2007002382A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento del cancer a la piel.
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
NO20075849L (no) Fremgangsmater og preparater til behandling eller forebygging av kreft
BRPI0418181A (pt) emprego de 2-aminotetralinas substituìdas para prevenção do tratamento de morbus parkinson
EE200200263A (et) Telomeeride G-kvadrupleksstruktuuri fikseerivad ühendid, nende kasutamine ja terapeutilised kombinatsioonid
BRPI0618239A8 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos
PA8514901A1 (es) Metabolitos agonistas/antagonistas de estrogeno
BR0313081A (pt) Combinação de um inibidor de aromatase com um bisfosfanato
DOP2006000175A (es) Heterociclos de 1,4-dihidropiridina condensados, procesos para preparar los mismos, uso y composiciones que los contienen
BR0009194A (pt) Composição do resorcinol
BRPI0414701A (pt) uso de um composto de vitamina d, método de prevenção ou tratamnento de disfunção de bexiga em um paciente, composto de vitamina d, e, kit
GT199900083A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica.
UA87117C2 (ru) Применение пептидных соединений для лечения центральной невропатической боли
MXPA05009718A (es) Uso de un fibrato y orlistato para el tratamiento de obesidad.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 35/78 , A61P 35/00

Ipc: A61K 36/71 (2006.01), A61K 31/704 (2006.01), A61P

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 13, 10 E 32 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.